Connect Sign In
LabMind podcasts
|
December 1, 2022 |
ARUP Honored With Utah Business Magazine’s Best Companies To Work For Award ARUP’s culture of caring has earned it Utah Business magazine’s Best Companies To Work For Award for a fifth consecutive year. |
The condition of venous thromboembolism, illustrated here, can be treated using direct oral anticoagulants (DOACs) such as direct factor Xa inhibitors. ARUP’s new chromogenic assays can be used to help assess treatment efficacy. |
November 28, 2022 |
New ARUP Tests Measure Levels of Direct Factor Xa Inhibitors to Ensure Quality Patient Care Routine monitoring of patients taking direct factor Xa inhibitors is not required, but the efficacy and safety of this treatment can be measured with ARUP’s newest test offerings. |
ARUP Chief Medical Officer Jonathan Genzen, MD, PhD (left), and Lauren Pearson, DO, MPH, chief medical officer of ARUP at University of Utah Health, are coauthors of a newly published JAMA Research Letter that summarizes results of a survey of clinical labs to evaluate adoption of a new equation to assess kidney function based on creatinine in patient serum. The new equation eliminates adjustment factors for race. |
November 22, 2022 |
New Survey: ARUP Is Among Labs Addressing Systemic Bias in Kidney Function Testing ARUP CMOs are coauthors of a newly published JAMA Research Letter that summarizes how clinical labs are leading the way in eliminating inequality in healthcare. |
Lauren Pearson, DO, MPH, is the first appointed chief medical officer of ARUP at University of Utah Health. Her new role will support ARUP’s commitment to continuous quality improvement for clinical laboratory services across the University of Utah Health system. |
November 17, 2022 | Lauren Pearson, DO, MPH, has been appointed to serve as the first chief medical officer of ARUP at University of Utah Health to support ARUP’s mission to provide the highest quality diagnostic care. |
The 36th Annual Park City Anatomic Pathology Update will offer an opportunity for pathologists to connect and share best practices in hematopathology and genitourinary (GU) pathology, including how to apply the latest updates from the World Health Organization (WHO) on the classification of tumors. |
November 16, 2022 |
Park City Anatomic Pathology Update Promises Guidance on Practical Application of Latest WHO Updates The University of Utah Department of Pathology and ARUP Laboratories will host the 36th Annual Park City Anatomic Pathology Update from February 5–9, 2023. |
ARUP President and Chief Scientific Officer Tracy George, MD (center), joins Kate Benedict, worldwide vice president/general manager of vascular access devices at BD, and Jared Bauer, CEO of Seek Labs, on a Workplace Innovation panel at the 2022 BioHive Summit to discuss workforce retention. |
November 11, 2022 |
President Tracy George, MD, Discusses ARUP’s Employee Focus at the 2022 BioHive Summit ARUP President and CSO Tracy George, MD, joined industry leaders and stakeholders at the 13th annual BioHive Summit Thursday to discuss ARUP’s employee focus, staff retention, and company culture. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat